Pharmaceutical policy and economic evaluations lost in political economy: Case study of Croatia

Abstract: Efficiency and transparency of pricing and reimbursement (P&R) rules and procedures as well as their implementation in South-eastern Europe lag substantially behind Western European practice. This mosaic seminar aims to shorty present the P&R framework in SEE with the focus Croatia. Next, I will discuss the results of the analysis conducted for the World Bank on Croatian healthcare system with the focus on future development in the pharmaceutical policy and regulation (with a special focus on the oncology sector). In attempt to contribute to improving the P&R framework in Croatia, I will discuss our recent work on the ICER threshold and the related equity-related considerations (based also on the inputs from the past funding decisions and the interviews with stakeholders). Finally, I will discuss our future research agenda involving indication-based pricing and wrap up with a few notes on the political economy and the usefulness of ICERs in European jurisdictions where the institutional capacity in the area of health technology assessment is limited.

Join Zoom Meeting
https://york-ac-uk.zoom.us/j/93281910193?pwd=MGVuNUQzSzBuTjdZSFl2eGN4N0hldz09
Meeting ID: 932 8191 0193
Passcode: 092487